Spontaneous and genetically engineered animal models: use in preclinical cancer drug development

被引：156

作者：

Hansen, K ^{[1
]}

Khanna, C ^{[1
]}

机构：

[1] NCI, Canc Res Ctr, Comparat Oncol Program, NIH, Rockville, MD USA

来源：

EUROPEAN JOURNAL OF CANCER | 2004年 / 40卷 / 06期

关键词：

cancers; GEM; mouse; transgenic; canine comparative; spontaneous;

D O I：

10.1016/j.ejca.2003.11.031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The preclinical development of anticancer drugs has been based primarily on the transplantation of murine or human cancers into mice. Alternatives to these transplantation models are animals that naturally develop cancers with features relevant to the human disease. The first group of these models arises in mice that are genetically engineered to develop cancer. The second group includes pet dogs and cats that naturally develop cancer. This review will discuss the use and integration of these spontaneous cancer models into a comprehensive and comparative approach to preclinical drug development. Examples of their successful use and an outline of their relative strengths and weaknesses will be provided. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：858 / 880

页数：23

共 152 条

[21]

DEWHIRST MW, 1989, RADIOL CLIN N AM, V27, P509

[22] Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer [J].

Dickerson, KB ;

Fosmire, S ;

Padilla, ML ;

Modiano, JF ;

Helfand, SC .

JOURNAL OF IMMUNOTHERAPY, 2002, 25 (01) :36-45

[23] Noninvasive fluorescent imaging reliably estimates biomass in vivo [J].

Diehn, FE ;

Costouros, NG ;

Miller, MS ;

Feldman, AL ;

Alexander, HR ;

Li, KCP ;

Libutti, SK .

BIOTECHNIQUES, 2002, 33 (06) :1250-+

[24]

DINNEY CPN, 1992, CANCER RES, V52, P1155

[25] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].

DONEHOWER, LA ;

HARVEY, M ;

SLAGLE, BL ;

MCARTHUR, MJ ;

MONTGOMERY, CA ;

BUTEL, JS ;

BRADLEY, A .

NATURE, 1992, 356 (6366) :215-221

[26]

DORN CR, 1968, JNCI-J NATL CANCER I, V40, P307

[27] In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma [J].

Dow, SW ;

Elmslie, RE ;

Willson, AP ;

Roche, L ;

Gorman, C ;

Potter, TA .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2406-2414

[28] TIME-COURSE DEVELOPMENT OF DIFFERENTIATED HEPATOCARCINOMA AND LUNG METASTASIS IN TRANSGENIC MICE [J].

DUBOIS, N ;

BENNOUN, M ;

ALLEMAND, I ;

MOLINA, T ;

GRIMBER, G ;

DAUDETMONSAC, M ;

ABELANET, R ;

BRIAND, P .

JOURNAL OF HEPATOLOGY, 1991, 13 (02) :227-239

[29]

FIDLER IJ, 1989, INVAS METAST, V9, P75

[30]

Firat H, 1999, EUR J IMMUNOL, V29, P3112, DOI 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO

← 1 2 3 4 5 6 7 8 9 10 →